Canada markets open in 3 hours 26 minutes

Revelation Biosciences, Inc. (REVB)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.9300+0.2500 (+14.88%)
At close: 04:00PM EDT
1.8493 -0.08 (-4.18%)
After hours: 07:59PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
Cash flows from operating activities
Net Income
-13,482
-120.254
-10,830
-11,987
Depreciation & amortization
25.048
25.049
25.048
16.782
Stock based compensation
374.667
155.721
301.116
470.878
Change in working capital
-97.81
982.135
-730.971
356.22
Accounts Payable
-1,171
749.66
-666.042
-269.64
Other working capital
-13,135
-7,286
-11,219
-11,223
Other non-cash items
29.608
-
14.96
52.384
Net cash provided by operating activites
-13,151
-7,286
-11,219
-11,091
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-131.963
Net cash used for investing activites
16.153
-
0
-131.963
Cash flows from financing activities
Debt repayment
-
0
-3,297
0
Common stock issued
11,713
14,030
4,451
599.996
Common stock repurchased
0
-5
-
-
Other financing activites
-
-
11,533
-
Net cash used privided by (used for) financing activities
15,193
14,025
15,198
8,005
Net change in cash
2,058
6,739
3,978
-3,218
Cash at beginning of period
4,137
5,253
1,275
4,492
Cash at end of period
6,195
11,992
5,253
1,275
Free Cash Flow
Operating Cash Flow
-13,151
-7,286
-11,219
-11,091
Capital Expenditure
-
-
-
-131.963
Free Cash Flow
-13,135
-7,286
-11,219
-11,223